Bardo Foundation Inc

2022 MARKED A YEAR OF DYNAMIC GROWTH AND IMPACTFUL CONTRIBUTIONS FOR THE BARDO FOUNDATION, AS WE CELEBRATED OUR FIRST FULL YEAR OF OPERATIONS. THROUGHOUT THE YEAR, WE UNDERTOOK SEVERAL INITIATIVES, ALIGNING WITH OUR MISSION TO COMBAT OSTEOSARCOMA AND SUPPORT AFFECTED INDIVIDUALS AND THEIR FAMILIES. **THE BARDO OPEN 2022:** WE SUCCESSFULLY ORGANIZED OUR INAUGURAL CHARITY GOLF TOURNAMENT, THE BARDO OPEN 2022, DRAWING SIGNIFICANT PARTICIPATION AND RAISING AWARENESS ABOUT OSTEOSARCOMA. **SUPPORTING HOSPITALIZED CHILDREN:** DEMONSTRATING OUR COMMITMENT TO PEDIATRIC CARE, WE DONATED IPADS TO THE WARD OF A HOSPITAL TREATING CHILDREN WITH OSTEOSARCOMA, PROVIDING EDUCATIONAL AND RECREATIONAL SUPPORT DURING THEIR TREATMENT. **WHITE HOUSE INVITATION:** OUR EFFORTS WERE RECOGNIZED AT A NATIONAL LEVEL AS WE WERE HONORED TO RECEIVE AN INVITATION TO THE WHITE HOUSE FOR THE CHILDHOOD CANCER MOONSHOT EVENT. THIS PRESTIGIOUS GATHERING FOCUSED ON REDUCING CANCER-RELATED DEATHS AND EMPHASIZED OUR ROLE IN THE BROADER FIGHT AGAINST CHILDHOOD CANCER. **GROUNDBREAKING RESEARCH INITIATIVES:** WE CO-FUNDED A PIONEERING CHILDHOOD CANCER RESEARCH PROJECT LED BY PROFESSOR NANCY DEMORE FROM THE MEDICAL UNIVERSITY OF SOUTH CAROLINA. ADDITIONALLY, WE SUPPORTED A PILOT STUDY EXPLORING CANCER IMMUNOTHERAPY FOR OSTEOSARCOMA PATIENTS IN COLLABORATION WITH THE CHILDREN'S CANCER RESEARCH INSTITUTE IN VIENNA, AUSTRIA. **INTERNATIONAL COLLABORATION AND AWARENESS:** ALONGSIDE DR. JUSTIN BAKER, MD FROM ST. JUDE CHILDREN'S RESEARCH HOSPITAL, WE PARTNERED WITH BARNEKREFTFORENINGEN AND DR. ANJA LEE FROM OSLO UNIVERSITY HOSPITAL FOR A CONFERENCE IN NORWAY, HIGHLIGHTING THE IMPORTANCE OF PEDIATRIC PALLIATIVE CARE. **INTERNATIONAL CHILDHOOD CANCER DAY:** ON FEBRUARY 15TH, THE BARDO FOUNDATION UTILIZED 24 MINUTES OF DONATED AIRTIME ON A LARGE SCREEN IN TIMES SQUARE TO BRING ATTENTION TO OUR MISSION AND THE URGENT NEED FOR A CURE FOR OSTEOSARCOMA. **MIB FACTOR 2022 CONFERENCE:** WE PROUDLY SUPPORTED MIB FACTOR 2022, A KEY CONFERENCE UNITING OSTEOSARCOMA RESEARCHERS, CLINICIANS, PATIENTS, AND FAMILIES TO COLLABORATE ON ADVANCING TREATMENTS AND IMPROVING PATIENT OUTCOMES. IN SUMMARY, 2022 WAS A YEAR WHERE THE BARDO FOUNDATION NOT ONLY EXPANDED ITS REACH BUT ALSO SOLIDIFIED ITS ROLE AS A VITAL CONTRIBUTOR TO THE GLOBAL FIGHT AGAINST OSTEOSARCOMA. WE LOOK FORWARD TO CONTINUING OUR MISSION WITH EVEN GREATER IMPACT IN THE YEARS AHEAD.